The global biochips market was valued at $xx billion in 2019, and is predicted to garner $37.24 billion by 2028, growing at a CAGR of 13.41% during the forecast period. The base year considered for the study is 2018, while the forecast period is 2019-2028. The rising incidences of cancer are anticipated to augment the demand for detection techniques. As per the World Health Organization, cancer is among the leading cause of mortality and morbidity, and in the year 2018, it was responsible for around 18.1 million new cases and 9.6 million deaths.

GLOBAL BIOCHIPS MARKET FORECAST 2019-2028

Global Biochips Market By Type (dna Chips, Lab On A Chip, Protein Chips, Other Chips) By Substrate Materials (glass, Polymers, Silicon, Other Substrate Materials) By End-users (biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centres, Academic & Research Institute) By Geography.

Request free sample

The global biochips market was valued at $xx billion in 2019, and is predicted to garner $37.24 billion by 2028, growing at a CAGR of 13.41% during the forecast period. The base year considered for the study is 2018, while the forecast period is 2019-2028.

The global biochips market growth is propelled by the following factors:

  • Rising incidences of chronic diseases
  • Growing interest in personalized medicines
  • Application of proteomics and genomics in cancer research
  • Rapidly growing use of point-of-care testing diagnostics

Biochips MarketTo know more about this report, request a free sample copy.

The rising incidences of cancer are anticipated to augment the demand for detection techniques. As per the World Health Organization, cancer is among the leading cause of mortality and morbidity, and in the year 2018, it was responsible for around 18.1 million new cases and 9.6 million deaths. Though the rising cases of chronic diseases and cancer act as primary drivers, Inkwood research analysts expect a rapid increase in demand for point-of-care diagnosis of COVID-19 to be the newly emerging market enabler, which is expected to propel the biochips market over the coming years. Many biotech companies are in the race to develop systems to test for COVID-19 with quick turnaround results, and this agenda is on their high priority to-do-list. Several biotech and pharmaceutical companies are collaborating to develop tests, which can be carried out on-the-spot and detect the existence of the virus in a few minutes. For instance, Randox Laboratories adapted its patented Biochip Array Technology (BAT) to develop a new test for the rapid and accurate diagnosis of the coronavirus.

In 2019, the majority of the market share was captured by the lab on a chip category in the type segment. The lab-on-a-chip concept targets at miniaturizing laboratory procedures to allow automation and parallelization through microfluidic chips, which are capable of handling minute sample volumes. Lab-on-a-chip (LOC) devices can save a lot of time, and reagents as samples are analyzed where they are generated. It also reduces chemical waste and exposure to dangerous substances. With the number of applications growing rapidly, it is also anticipated to be the fastest-growing type in the market. LOC devices armed with electrodes for particle sorting, packing, cell or particle detection, electrophoresis, PCR, etc., are available commercially. These devices are also proven to be an exceptional tool for cell research, such as cell sorting and cell growth, and for fields, such as artificial disease models and toxicity studies. Lab-on-a-chip devices also cover organ-on-a-chip devices, which are a type of 3D cell culture that can reproduce the organs on a small slide. Several organ-on-a-chip models, like heart-on-chip, liver-on-chip, lung-on-chip, muscle-on-chip, etc., are commercially available.

On the contrary, the high costs pose a significant challenge for its adoption in the market. Also, end users are skeptical about the return on investment (ROI). The biochip technology is gaining traction in the fields of medicine due to its high potential in understanding disease mechanisms at the molecular level. However, many research institutes are unaware of the clinical utility of biochips and refrain from investing in the technology even for trial because of its extravagant cost. Therefore, high pricing is one of the major deterrents in the use of biochips in routine research projects that are strapped for investment. Moreover, the complexity of biological systems & the availability of alternative technology, i.e., next-generation sequencing (NGS) technology, creates hurdles in the growth of the market globally.

The report on the global biochips market includes segmentation analysis on the basis of type, end-user, and substrate materials.

Market by Type:

  • DNA Chip
    • Agricultural Biotechnology
    • Cancer Diagnosis & Treatment
    • Drug Discovery
    • Gene Expression
    • Genomics
    • Single Nucleotide Polymorphism (SNP) Genotyping
    • Other DNA Chips
  • Lab on a chip
    • Clinical Diagnostics
    • Drug Discovery
    • Genomics
    • Point of Care & In Vitro Diagnosis
    • Proteomics
    • Other Lab on a Chip
  • Protein chip
    • Diagnostics
    • Drug Discovery
    • Expression Profiling
    • High Throughput Screening
    • Proteomics
    • Other Protein Chips
  • Others
    • Cell Arrays
    • Tissue Arrays

Market by End-users:

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostics Centers
  • Academic and Research Institute

Market by Substrate Materials:

  • Glass
  • Polymers
  • Silicon
  • Other Substrate Materials

Geographically, the global biochips market has been segmented on the basis of four major regions, which includes:

  • North America: the United States and Canada
  • Europe: Russia, Belgium, Poland, the United Kingdom, Germany, France, Italy, and the Rest of Europe
  • Asia Pacific: Thailand, Vietnam, Australia & New Zealand, China, Japan, India, South Korea, Indonesia, and the Rest of Asia Pacific
  • Rest of World: Latin America, the Middle East & Africa

In 2019, the North America region held a dominant position in the global landscape by capturing the largest market share of 41.04%, due to the increasing awareness about biochips and their widespread applicability in different fields such as personalized medicine, agri-genomics, clinical diseases, and others. The United States dominated the North America market in 2019, owing to the presence of a large pool of patients opting for personalized medications, and the growing prevalence of cancer & other immunological medical conditions. U.S. Food and Drug Administration (FDA), Defense Advanced Research Projects Agency (DARPA), and National Institutes of Health (NIH), are together investing nearly $150 million in research funding to speed the development of the chips for use in testing the effects of chemical and radiation exposures on humans. Moreover, the Department of Health and Human Services (HHS) declared the allocation of funds, to develop microfluidic platforms for blood testing, among neonatal and pediatric patients.

Furthermore, the Asia Pacific region is set to record the highest CAGR by the end of the forecast period. In the Asia Pacific, China and India jointly have a large pool of patients, making them highly opportunistic markets for investment. India is one of the most lucrative healthcare markets in the Asia Pacific region, owing to supportive government initiatives toward R&D in the field of biotechnology. There is an increasing number of researches taking place in India, which has boosted the demand for lab-on-a-chip (LOC) models, thus, helping the growth of the overall market. In addition, biochip startups have also initiated academic research, to bring in investment and transform the drug discovery industry. A team of scientists from the Indian Institute of Technology, Madras (IIT-M), in 2016, developed a lab on a chip diagnostic device to diagnose several diseases, which is both affordable and accessible even in resource-constrained settings. The team has also tested the device for the diagnosis of dengue. The Bengaluru-based biotech startup, Achira Labs, in 2016, boasted the technique of lab on a chip with its product, Acix 100. The product uses silk strips for diabetes, HIV, and other diseases.

Some of the leading players in the global biochips market are:

  • Randox Laboratories Ltd
  • Fluidigm Corporation
  • Bio-Rad Laboratories Inc
  • Cepheid
  • Illumina Inc
  • Agilent Technologies Inc
  • Others

Key strategies adopted by some of the biochips companies are:

In March, 2020, three new GenetiSure Cyto microarrays were developed by Agilent Technologies Inc. for prenatal and postnatal research. In April, 2020, Celsee, Inc., which provides consumables and instruments for the detection, analysis, and isolation, of single cells, was acquired by Bio-Rad Laboratories, Inc. Similarly, in March, 2020, Thermo Fisher Scientific Inc. entered into definitive agreement to acquire QIAGEN N.V.

Key findings of the global biochips market are:

  • The biochips market has huge growth opportunities in the sub-continent of Asia. The growth opportunity in the Asian region is mainly due to the medicinal importance of miniaturized biological microarray chips that have produced a transforming effect on the global healthcare industry.
  • The rapid rise in the aging population is one of the major growth opportunities for the market. The geriatric population is more vulnerable to chronic disorders, which increases the demand for biochips that are used to screen and diagnose disorders in aged people.
  • Several players in the market, including Affymetrix, Illumina, Partek, and Arrayit, provide advanced software for microarray studies. Thus, the growth of the bioinformatics software sector should propel market growth.
  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
    • DEVELOPMENT OF BIOCHIPS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISING INCIDENCES OF CHRONIC DISEASES
      • GROWING INTEREST IN PERSONALIZED MEDICINES
      • APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
      • RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
    •    KEY RESTRAINTS
      • HIGH INSTRUMENTATION COST
      • LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
      • AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
      • COMPLEXITY OF BIOLOGICAL SYSTEMS
      • LACK OF COMMON REGULATORY STANDARDS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON BIOCHIPS
    • KEY INVESTMENT INSIGHTS
    •    PORTER’S FIVE FORCE ANALYSIS
      • BUYER POWER
      • SUPPLIER POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    •    VALUE CHAIN ANALYSIS
      • RESEARCH & DEVELOPMENT
      • RAW MATERIALS
      • MANUFACTURING
      • WHOLESALERS/RETAILERS/DISTRIBUTORS
      • END-USER
    •    KEY BUYING CRITERIA
      • COST
      • APPLICATIONS
      • PRODUCT TYPE
    • REGULATORY FRAMEWORK
  2. MARKET BY TYPE
    •    DNA CHIPS
      • AGRICULTURAL BIOTECHNOLOGY
      • CANCER DIAGNOSIS & TREATMENT
      • DRUG DISCOVERY
      • GENE EXPRESSION
      • GENOMICS
      • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
      • OTHER DNA CHIPS
    •    LAB ON A CHIP
      • CLINICAL DIAGNOSTICS
      • DRUG DISCOVERY
      • GENOMICS
      • POINT OF CARE & IN VITRO DIAGNOSIS
      • PROTEOMICS
      • OTHER LAB ON A CHIP
    •    PROTEIN CHIPS
      • DIAGNOSTICS
      • DRUG DISCOVERY
      • EXPRESSION PROFILING
      • HIGH THROUGHPUT SCREENING
      • PROTEOMICS
      • OTHER PROTEIN CHIPS
    •    OTHER TYPES
      • CELL ARRAYS
      • TISSUE ARRAYS
  1. MARKET BY SUBSTRATE MATERIALS
    • GLASS
    • POLYMERS
    • SILICON
    • OTHER SUBSTRATE MATERIALS
  2. MARKET BY END-USER
    • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • HOSPITALS AND DIAGNOSTICS CENTERS
    • ACADEMIC AND RESEARCH INSTITUTES
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • UNITED STATES
      • CANADA
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • INDONESIA
      • THAILAND
      • VIETNAM
      • AUSTRALIA & NEW ZEALAND
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES INC
    • AGILENT TECHNOLOGIES INC
    • BIOCHAIN INSTITUTE INC
    • BIOMÉRIEUX SA
    • BIO-RAD LABORATORIES INC
    • CEPHEID
    • CYBRDI INC
    • F HOFFMANN-LA ROCHE LTD
    • FLUIDIGM CORPORATION
    • GE HEALTHCARE
    • ILLUMINA INC
    • MERCK KGAA
    • PERKINELMER INC
    • RANDOX LABORATORIES LTD
    • THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOCHIPS

TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: GLOBAL BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: GLOBAL BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: GLOBAL DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 10: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 12: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 14: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 16: GLOBAL GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 17: GLOBAL GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 18: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 19: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 20: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 22: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 24: GLOBAL LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: GLOBAL LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 26: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 31: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 32: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 34: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 35: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 36: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 37: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 38: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 39: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 40: GLOBAL PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 41: GLOBAL PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 42: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 43: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 44: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 45: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 46: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 47: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 48: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 49: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 50: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 51: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 52: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 53: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 54: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 55: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 56: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 57: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 58: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 59: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 60: GLOBAL CELL ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 61: GLOBAL CELL ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 62: GLOBAL TISSUE ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 63: GLOBAL TISSUE ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 64: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS

TABLE 65: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 66: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 67: GLOBAL GLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 68: GLOBAL GLASS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 69: GLOBAL POLYMERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 70: GLOBAL POLYMERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 71: GLOBAL SILICON MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 72: GLOBAL SILICON MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 73: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 74: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 75: GLOBAL BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 76: GLOBAL BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 77: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 78: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 79: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 80: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 81: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 82: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 83: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 84: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 85: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 86: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 87: EUROPE BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 88: EUROPE BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 89: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 90: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 91: REST OF WORLD BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 92: REST OF WORLD BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: DEVELOPMENT OF BIOCHIPS

FIGURE 2: KEY INVESTMENT INSIGHTS

FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: KEY BUYING CRITERIA

FIGURE 8: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019

FIGURE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)

FIGURE 10: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019

FIGURE 11: GLOBAL BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)

FIGURE 12: GLOBAL BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)

FIGURE 13: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

FIGURE 14: GLOBAL BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)

FIGURE 15: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

FIGURE 16: GLOBAL BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)

FIGURE 17: GLOBAL BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)

FIGURE 18: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)

FIGURE 19: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019

FIGURE 20: GLOBAL BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)

FIGURE 21: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

FIGURE 22: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

FIGURE 23: GLOBAL BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)

FIGURE 24: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

FIGURE 25: GLOBAL BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)

FIGURE 26: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

FIGURE 27: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019

FIGURE 28: GLOBAL BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)

FIGURE 29: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

FIGURE 30: GLOBAL BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)

FIGURE 31: GLOBAL BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)

FIGURE 32: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

FIGURE 33: GLOBAL BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

FIGURE 34: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)

FIGURE 35: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019

FIGURE 36: GLOBAL BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)

FIGURE 37: GLOBAL BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)

FIGURE 38: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019

FIGURE 39: GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)

FIGURE 40: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)

FIGURE 41: GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)

FIGURE 42: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)

FIGURE 43: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

FIGURE 44: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)

FIGURE 45: GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)

FIGURE 46: GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)

FIGURE 47: NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 48: UNITED STATES BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 49: CANADA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 50: EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 51: UNITED KINGDOM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 52: GERMANY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 53: FRANCE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 54: ITALY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 55: RUSSIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 56: BELGIUM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 57: POLAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 58: REST OF EUROPE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 59: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 60: CHINA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 61: JAPAN BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 62: INDIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 63: SOUTH KOREA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 64: INDONESIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 65: THAILAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 66: VIETNAM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 67: AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 68: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 69: REST OF WORLD BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 70: LATIN AMERICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 71: MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

  1. MARKET BY TYPE
    •    DNA CHIPS
      • AGRICULTURAL BIOTECHNOLOGY
      • CANCER DIAGNOSIS & TREATMENT
      • DRUG DISCOVERY
      • GENE EXPRESSION
      • GENOMICS
      • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
      • OTHER DNA CHIPS
    •    LAB ON A CHIP
      • CLINICAL DIAGNOSTICS
      • DRUG DISCOVERY
      • GENOMICS
      • POINT OF CARE & IN VITRO DIAGNOSIS
      • PROTEOMICS
      • OTHER LAB ON A CHIP
    •    PROTEIN CHIPS
      • DIAGNOSTICS
      • DRUG DISCOVERY
      • EXPRESSION PROFILING
      • HIGH THROUGHPUT SCREENING
      • PROTEOMICS
      • OTHER PROTEIN CHIPS
    •    OTHER TYPES
      • CELL ARRAYS
      • TISSUE ARRAYS
  1. MARKET BY SUBSTRATE MATERIALS
    • GLASS
    • POLYMERS
    • SILICON
    • OTHER SUBSTRATE MATERIALS
  2. MARKET BY END-USER
    • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • HOSPITALS AND DIAGNOSTICS CENTERS
    • ACADEMIC AND RESEARCH INSTITUTES
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • UNITED STATES
      • CANADA
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • INDONESIA
      • THAILAND
      • VIETNAM
      • AUSTRALIA & NEW ZEALAND
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type